| http://www.w3.org/ns/prov#value | - Genopole(R) and MAbgene will together review opportunities to diversify their production technologies, which could result in the establishment of a second biomanufacturing center based on yeast-, bacteria- or plant cell-based techniques, whilst also opening out into sectors other than healthcare.
|
